Lantern Pharma Inc. (LTRN) earnings

LTRN earnings moved a median of +0.16% by the close. Quarterly and annual LTRN reports and results, each read against the price at its own news timestamp. Back to the LTRN overview →

31 measured LTRN earnings events.

Where these LTRN earnings landedvs 29 measured LTRN earnings reactions
LTRN earningsMiddle 50% · -4.82% to +1.67%Zero: 0.00%Median: +0.16%Median +0.16%-8.00%0+8.00%
Middle 50% of LTRN earnings reactions-4.82% to +1.67%
Median reaction (to close)+0.16%
Measured reactions29
Point-in-time · zero look-ahead

Half of the 29 LTRN earnings events with a measured close landed between -4.82% and +1.67%; 52% closed up.

DateHeadlineEvent5-minTo close
Form 10-Q Lantern Pharma Inc. For: Jun 30SEC filing · Form 10-Q-4.38%+5.58%
Lantern Pharma Reports Second Quarter 2026 Financial Results and Provides Business UpdatePress release-4.38%+5.58%
Lantern Pharma to Report Second Quarter 2026 Operating & Financial Results on August 14th, 2026 at 9:00 a.m. ETPress release+0.00%-1.38%
Form 10-Q Lantern Pharma Inc. For: Mar 31SEC filing · Form 10-Q-1.34%+0.33%
Lantern Pharma Reports First Quarter 2026 Financial Results and Provides Business UpdatesPress release-1.34%+0.33%
Lantern Pharma to Report First Quarter 2026 Operating & Financial Results on May 15th, 2026Press release+2.19%+0.49%
Form 10-K/A Lantern Pharma Inc. For: Dec 31SEC filing · Form 10-K-0.95%-1.91%
Form 10-K Lantern Pharma Inc. For: Dec 31SEC filing · Form 10-K+3.53%-2.84%
Lantern Pharma Reports Third Quarter 2025 Financial Results and Provides Business UpdatesPress release+0.28%—
Form 10-Q Lantern Pharma Inc. For: Sep 30SEC filing · Form 10-Q+0.28%—
Lantern Pharma to Report Third Quarter 2025 Operating & Financial Results on November 13th, 2025 at 9:00 a.m. ETPress release+0.57%-4.82%
Form 10-Q Lantern Pharma Inc. For: Jun 30SEC filing · Form 10-Q-5.41%+1.11%
Lantern Pharma Reports Second Quarter 2025 Financial Results and Business UpdatesPress release-5.41%+1.11%
Form 10-Q Lantern Pharma Inc. For: Mar 31SEC filing · Form 10-Q+0.98%-5.85%
Lantern Pharma Reports First Quarter 2025 Financial Results and Business UpdatesPress release+0.98%-5.85%
Lantern Pharma to Report First Quarter 2025 Operating & Financial Results on May 15th, 2025 at 9:00 a.m. ETPress release+0.12%-11.26%
Form 10-K/A Lantern Pharma Inc. For: Dec 31SEC filing · Form 10-K-2.15%-0.56%
Form 10-K Lantern Pharma Inc. For: Dec 31SEC filing · Form 10-K-3.48%-4.83%
Form 10-Q Lantern Pharma Inc. For: Sep 30SEC filing · Form 10-Q+0.63%+14.63%
Lantern Pharma Reports Third Quarter 2024 Financial Results and Business UpdatesPress release+0.63%+14.63%
Lantern Pharma to Report Third Quarter 2024 Operating & Financial Results on November 7th, 2024 at 4:30 p.m. ETPress release+0.00%-4.14%
Form 10-Q Lantern Pharma Inc. For: Jun 30SEC filing · Form 10-Q-3.44%-8.12%
Lantern Pharma Reports Second Quarter 2024 Financial Results and Business UpdatesPress release-3.44%-8.12%
Lantern Pharma to Report Second Quarter 2024 Operating & Financial Results on August 8th, 2024 at 4:30 p.m. ETPress release-0.33%-3.33%
Form 10-Q Lantern Pharma Inc. For: Mar 31SEC filing · Form 10-Q+9.59%+0.16%
Lantern Pharma Reports First Quarter 2024 Financial Results and Business HighlightsPress release+9.59%+0.16%
Lantern Pharma to Report First Quarter 2024 Operating & Financial Results on May 9th, 2024 at 4:30 p.m. ETPress release+1.11%+1.67%
Form 10-K Lantern Pharma Inc. For: Dec 31SEC filing · Form 10-K-15.65%-18.59%
Form 10-Q Lantern Pharma Inc. For: Sep 30SEC filing · Form 10-Q+0.00%+26.87%
Lantern Pharma Reports Third Quarter 2023 Financial Results and Operational HighlightsPress release+0.00%+26.87%
Lantern Pharma to Report Third Quarter 2023 Operating & Financial Results on November 8th, 2023 at 4:30 p.m. ETPress release-1.65%+5.79%
That’s how LTRN usually reacts to earnings — get an email when it moves on news →
Keep exploring

More LTRN: analyst actions → · SEC filings → · LTRN overview →